Next Article in Journal
Shared IVIVR for Five Commercial Enabling Formulations Using the BiPHa+ Biphasic Dissolution Assay
Next Article in Special Issue
Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain—Narrative Review
Previous Article in Journal
On Absorption Modeling and Food Effect Prediction of Rivaroxaban, a BCS II Drug Orally Administered as an Immediate-Release Tablet
Previous Article in Special Issue
Novel Fluorinated Poly (Lactic-Co-Glycolic acid) (PLGA) and Polyethylene Glycol (PEG) Nanoparticles for Monitoring and Imaging in Osteoarthritis
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(2), 284; https://doi.org/10.3390/pharmaceutics13020284
Action Date Notes Link
article xml file uploaded 21 February 2021 10:19 CET Original file -
article xml uploaded. 21 February 2021 10:19 CET Update https://www.mdpi.com/1999-4923/13/2/284/xml
article pdf uploaded. 21 February 2021 10:19 CET Version of Record https://www.mdpi.com/1999-4923/13/2/284/pdf
article supplementary file uploaded. 21 February 2021 10:19 CET - https://www.mdpi.com/1999-4923/13/2/284#supplementary
article html file updated 21 February 2021 10:21 CET Original file -
article html file updated 25 July 2022 04:23 CEST Update https://www.mdpi.com/1999-4923/13/2/284/html
Back to TopTop